Đang chuẩn bị liên kết để tải về tài liệu:
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Although the incidence of glioma is relatively low, it is the most malignant tumor of the central nervous system. The prognosis of high-grade glioma patient is very poor due to the difficulties in complete resection and resistance to radio-/chemotherapy. Therefore, it is worth investigating the molecular mechanisms involved in glioma drug resistance. |

TÀI LIỆU LIÊN QUAN